+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Pain Drug Market - Global Forecast 2026-2032- Product Image
Osteoarthritis Pain Drug Market - Global Forecast 2026-2032- Product Image
New

Osteoarthritis Pain Drug Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995456
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The osteoarthritis pain drug market is facing significant transformation, presenting both challenges and opportunities for stakeholders seeking long-term growth. Spurred by clinical progress and advances in care delivery, market participants are reevaluating their strategies amid shifting technological and operational priorities. Ensuring alignment between product innovation and execution has become essential for sustained market relevance.

Market Snapshot: Osteoarthritis Pain Drug Market Growth

The osteoarthritis pain drug market demonstrated notable expansion, moving from USD 9.45 billion in 2025 to USD 10.31 billion in 2026, and is forecasted to reach USD 17.99 billion by 2032 with a CAGR of 9.62%. This consistent upward trend is driven by the evolving needs of patients, adaptation of care models, and higher regulatory scrutiny, with an increasing emphasis on value-based outcomes. As demand rises globally, market participants must adapt to more dynamic regulatory environments and increased complexity across approval, reimbursement, and commercialization pathways.

Scope & Segmentation

This report delivers in-depth segmentation and comprehensive analysis by therapeutic class, administration route, user groups, and regional market dynamics, delivering insight for targeted strategy and resource allocation:

  • Therapeutic Classes: Encompasses corticosteroids, nonsteroidal anti-inflammatory drugs, cyclooxygenase-2 inhibitors, symptomatic slow-acting drugs, viscosupplements, and injectable biologic agents; each addressing distinct pain mechanisms and patient profiles.
  • Routes of Administration: Includes oral forms (capsules, tablets, liquids), injectables (intra-articular, intramuscular), and topical delivery (creams, gels, and patches) to meet varied patient preferences and clinical requirements.
  • Distribution Channels: Analyzes roles of hospital pharmacies, retail pharmacies, and online pharmacies in broadening patient access and supporting product availability.
  • End Users: Focuses on clinics, home healthcare services, and hospitals, each representing specific workflow, care delivery, and support demands.
  • Patient Age Groups: Segmentations include adolescents under 18, adults aged 18–64, and those 65 and older, reflecting unique comorbidity profiles and challenges in safety and tolerability.
  • Disease Severity: Assesses strategies for treating mild, moderate, and severe disease presentations, guiding product positioning, trial design, and treatment escalation pathways.
  • Geographies: Evaluates Americas; Europe, Middle East & Africa; and Asia-Pacific regions, each shaped by specific regulatory approaches, access barriers, and localization requirements impacting commercialization.
  • Technological Trends: Highlights integration of digital health tools, innovation in advanced injectables, new topical formulations, and expanded adoption of biologic treatments, supporting diversification and enhanced clinical outcomes.

Key Takeaways

  • Pharmaceutical and biotech providers benefit by integrating real-world evidence and clinical trial findings to improve market positioning and influence payer decisions.
  • Market access requires tailored strategies that account for distinct regional regulatory landscapes, reimbursement models, and procurement practices.
  • Outpatient procedural centers are increasingly integral to the administration of novel injectable therapies, shifting market opportunities away from traditional hospital settings and innovating care delivery models.
  • Manufacturers seeking strong payer engagement deploy comparative effectiveness studies and health economics modeling to support value proposition and reimbursement applications.
  • Segmentation based on patient age and disease severity enables companies to refine recruitment, messaging, and distribution tactics, optimizing uptake and ongoing adherence.
  • Collaboration among biotech firms, pharmaceutical giants, and contract manufacturers enhances the scalability and timely availability of complex therapies within the global market supply chain.

Tariff Impact on Supply Chain and Procurement

Amid evolving U.S. tariffs, both global manufacturers and procurement teams are reexamining how they approach supplier selection, sourcing strategies, and localization of production. The shift toward regional partnerships and dual-sourcing enhances procurement agility and mitigates risk, while new contracting models are implemented to address upstream cost volatility. These changes influence cycle times, inventory management, and longer-term portfolio decisions, presenting pathways for vertical integration and supplier risk optimization.

Methodology & Data Sources

The report utilizes a blend of secondary literature review, structured expert interviews, and comparative regulatory analysis across key regions. Insights from qualitative research with clinicians, pharmacy directors, and payers ensure practical, actionable intelligence that reflects real-world stakeholder needs and supports decision-making.

Why This Report Matters

  • Provides targeted intelligence to inform product development, payer value articulation, and effective execution within complex osteoarthritis pain drug market environments.
  • Equips senior leaders, procurement, and commercial teams with foresight to anticipate supply chain and regulatory volatility, strengthening both market access and patient care strategies.
  • Supports evidence-driven decisions in portfolio planning, market segmentation, and partnership development to enable sustainable growth amid intensive competition.

Conclusion

Succeeding in the osteoarthritis pain drug market now depends on strategic integration of clinical, supply chain, and market access priorities. Organizations that adapt to these evolving imperatives will be positioned to drive advances in patient care while realizing steady commercial momentum.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Osteoarthritis Pain Drug Market, by Product Type
8.1. Corticosteroids
8.2. Cyclooxygenase 2 Inhibitors
8.3. Nonsteroidal Anti-Inflammatory Drugs
8.4. Symptomatic Slow Acting Drugs
8.5. Viscosupplements
9. Osteoarthritis Pain Drug Market, by Route Of Administration
9.1. Injectable
9.1.1. Intra Articular
9.1.2. Intramuscular
9.2. Oral
9.2.1. Capsules
9.2.2. Liquid
9.2.3. Tablets
9.3. Topical
9.3.1. Cream
9.3.2. Gel
9.3.3. Patch
10. Osteoarthritis Pain Drug Market, by Patient Age Group
10.1. Adolescents Under 18
10.2. Adults 18 64
10.3. Elderly 65+
11. Osteoarthritis Pain Drug Market, by Disease Severity
11.1. Mild
11.2. Moderate
11.3. Severe
12. Osteoarthritis Pain Drug Market, by End User
12.1. Clinics
12.2. Home Healthcare
12.3. Hospitals
13. Osteoarthritis Pain Drug Market, by Distribution Channel
13.1. Offline
13.2. Online
14. Osteoarthritis Pain Drug Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Osteoarthritis Pain Drug Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Osteoarthritis Pain Drug Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Osteoarthritis Pain Drug Market
18. China Osteoarthritis Pain Drug Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Bayer AG
19.7. GlaxoSmithKline plc
19.8. Johnson & Johnson
19.9. Merck & Co., Inc.
19.10. Novartis AG
19.11. Perrigo Company plc
19.12. Pfizer Inc.
19.13. Sandoz International GmbH
19.14. Sanofi S.A.
19.15. Teva Pharmaceutical Industries Ltd.
19.16. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CYCLOOXYGENASE 2 INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CYCLOOXYGENASE 2 INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CYCLOOXYGENASE 2 INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SYMPTOMATIC SLOW ACTING DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SYMPTOMATIC SLOW ACTING DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SYMPTOMATIC SLOW ACTING DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY VISCOSUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRA ARTICULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRA ARTICULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRA ARTICULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADOLESCENTS UNDER 18, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADOLESCENTS UNDER 18, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADOLESCENTS UNDER 18, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADULTS 18 64, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADULTS 18 64, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ADULTS 18 64, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ELDERLY 65+, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ELDERLY 65+, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ELDERLY 65+, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MILD, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MILD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MILD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MODERATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MODERATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY MODERATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEVERE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEVERE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SEVERE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 138. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 140. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 153. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 156. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 157. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 158. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 159. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 160. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 161. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. AFRICA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 177. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 178. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 179. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 180. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 181. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 182. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. ASEAN OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 186. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 187. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 188. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 189. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 190. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 191. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 192. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. GCC OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 207. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 208. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 209. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 210. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 211. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 212. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. BRICS OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 214. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 216. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 217. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 218. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 219. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 220. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 221. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 222. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 223. G7 OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 224. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 225. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 226. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 227. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 228. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 229. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 230. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 231. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 232. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NATO OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 246. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 247. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 248. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 249. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 250. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 251. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 252. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISEASE SEVERITY, 2018-2032 (USD MILLION)
TABLE 253. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. CHINA OSTEOARTHRITIS PAIN DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Osteoarthritis Pain Drug market report include:
  • AbbVie Inc.
  • Bayer AG
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Perrigo Company plc
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.31 Billion
Forecasted Market Value ( USD ) by 2032 $ 17.99 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Hip Osteoarthritis Pain Drug Market - Global Forecast 2025-2030 - Product Image

Hip Osteoarthritis Pain Drug Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Osteoarthritic Pain Drug Pipeline Analysis Report 2025 - Product Image

Osteoarthritic Pain Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Acute Pain Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Acute Pain Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 117 Pages
  • Global
From
Neuropathic Pain Drug Market - Global Forecast 2026-2032 - Product Image

Neuropathic Pain Drug Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Neuropathic Pain Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Neuropathic Pain Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Osteoarthritis Pain Drug Market

Analgesics are drugs used to relieve pain. Osteoarthritis pain is a common type of pain that can be treated with analgesics. Osteoarthritis is a degenerative joint disease that causes pain, stiffness, and swelling in the joints. Analgesics used to treat osteoarthritis pain include nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and opioids. NSAIDs are the most commonly used analgesics for osteoarthritis pain, as they reduce inflammation and pain. Acetaminophen is also used to reduce pain, but it does not reduce inflammation. Opioids are used for severe pain, but they can be addictive and have side effects. Companies in the Osteoarthritis Pain Drug market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.